60.7%, p = 0.049), while BRCA mutations showed a favorable trend.
← all phrases
“a favorable trend”
Sighted at
p=0.09
In the literature
Although fasting insulin did not change significantly, the 27.9% reduction in HOMA-IR in the combined group indicates a favorable trend toward enhanced insulin sensitivity, which may become significant in longer trials or larger cohorts.
Differences in mortality, pneumonia, sepsis, AKI, and reoperation did not reach statistical significance, although a favorable trend was observed for the optimized group ( Table 4 ). 3.5.
Conclusions: The addition of CDK4/6i to ET improves iDFS and shows a favorable trend in DRFS in early-stage HR+/HER2− breast cancer, highlighting the need for longer follow-up to clarify their long-term benefit. early-stage HR+/HER2− breast cancer CDK4/6 inhibitors endocrine therapy adjuvant therapy meta-analysis invasive disease-free survival abemaciclib ribociclib palbociclib Thi
We conducted an analysis with varying cutoffs to examine whether there was a favorable trend in PFS and OS in the EA group, even with different proportions of infusion cutoffs.
reported that a eucaloric ketogenic diet was associated with reduced mortality, fewer ICU admissions, and a favorable trend toward lower IL-6 levels [ 75 ].
Six-month survival showed a favorable trend, although not statistically significant in point analysis.
In that study, the 3-year PFS rate was 66.3% in the group that received DOS therapy and 60.2% in the group that received surgery plus postoperative S-1 therapy, indicating a favorable trend for the preoperative group [ 9 ].
Regarding prognostic impact, our data show a favorable trend in overall survival for patients who received targeted therapies guided by ctDNA results.
Subgroup analysis of PFS by demographics and baseline characteristics revealed a favorable trend for arm A and arm B versus arm C in most subgroups, with some exceptions; however, this should be treated with caution because of the small sample sizes ( Supplementary Fig. 2 A and B ).
The doubly robust IPTW-adjusted model at Month 1 also showed a favorable trend for FLACS (mean difference − 0.17 logMAR), although the 95% CI crossed zero.
Although the differences in specific pelvic floor dysfunction disorders did not reach statistical significance, a favorable trend was observed.
Although not statistically significant, CTD‐PH patients showed a favorable trend with high‐risk patients decreasing from 20% to 10%.
Concurrently, aortic atherosclerotic area, lipid levels, liver oxidative stress, and body inflammation were improved, showing a favorable trend of change.
Although the difference in OS (63.2 versus 51.1 months) did not reach statistical significance ( p = 0.156), a favorable trend was observed.
Additionally, a favorable trend has been observed following the significant decline between 2019 and 2020 due to the COVID-19 pandemic ( OECD, 2023 ).
Analysis using the Tapio decoupling model revealed that most cities exhibited developmental decoupling characteristics during the study period, indicating that the human and built environment systems generally maintained a favorable trend of coordinated development.
Conclusions Although a favorable trend is emerging, pooled data suggest that within the early treatment period (<12 weeks), BoNT-A may not be more effective than a placebo in reducing pPSS.
Notably, for SCLC patients with LM, a subgroup historically associated with limited treatment efficacy, even a modest extension in PFS may translate to meaningful symptom alleviation and could potentially signal a favorable trend in OS.
These findings indicate that main dishes and soups are the key protein sources in long-term care hospital meals, and the high inclusion of fish represents a favorable trend.
Among the studies included in this systematic review, only one study failed to achieve statistical significance in adverse event reduction; however, a favorable trend with dose reduction was reported [ 18 ].
CONCLUSIONS The study has demonstrated safety and feasibility of repeated infusions of MTX110 via CED in DMG patients with a favorable trend in overall survival warranting further trials with higher number of infusion pulses. status released display-pdf yes is-olf no is-manuscript no is-preprint no is-journal-matter no is-scanned no is-retracted no Collection date 2024 Jun.
Conclusions In this retrospective study of patients with nonparoxysmal AF after catheter ablation, dronedarone and amiodarone showed a favorable trend toward lower rates of overall early recurrence compared to propafenone.
In this study, although not statistically significant, the 30-day mortality rate in the emergent group (0%) was lower than that in the non-emergent group (25.0%), suggesting a favorable trend toward improved early outcomes with earlier intervention.
The results showed a favorable trend in OS in the preoperative CXRT group, although there was no statistically significant difference in either 3-year or 5-year OS rates because of the small number of enrolled patients [ 20 , 21 ].